In the last 12 months, insiders at IRONWOOD PHARMACEUTICALS INC ($IRWD) filed 178 transactions with the SEC: 3 open-market purchases totaling $460,539 and 73 sales totaling $33,249,126. Net insider sentiment: net selling.
IRONWOOD PHARMACEUTICALS INC operates in the Pharmaceutical preparations industry (Life sciences sector).
Most Active Insiders
- DENNER ALEXANDER J (Not found) — 13 transactions totaling $20,530,448
- MCCOURT Thomas A (Chief Executive Officer) — 29 transactions totaling $9,200,897
- John Minardo (Chief Legal Officer) — 20 transactions totaling $1,234,667
- Emany Sravan Kumar (SVP, Chief Financial Officer) — 12 transactions totaling $1,200,441
- Shetzline Michael (CMO,SVP,Head-Res&Drug) — 15 transactions totaling $1,016,521
View all SEC Filings for IRONWOOD PHARMACEUTICALS INC (IRWD).
Set Up your own filters →Recent Insider Transactions
| Transaction Date | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|
| March 17, 2026 | DENNER ALEXANDER J | Not found | S | Class A Common Stock | 6725000 | $3.05 | 9,450,744.0000 | 162,983,000 | 41.57% | 4.13% |
| March 13, 2026 | DENNER ALEXANDER J | Not found | A | Class A Common Stock | 4451 | $0.00 | 9,444,944.0000 | 162,983,000 | 0.05% | 0.00% |
| March 17, 2026 | DENNER ALEXANDER J | Not found | S | Class A Common Stock | 5800 | $3.31 | 9,444,944.0000 | 162,983,000 | 0.06% | 0.00% |
| March 10, 2026 | John Minardo | Chief Legal Officer | A | Class A Common Stock | 136612 | $0.00 | 500,498.0000 | 162,983,000 | 37.54% | 0.08% |
| March 10, 2026 | Martini Gregory S. | Chief Financial Officer | A | Class A Common Stock | 136612 | $0.00 | 297,213.0000 | 162,983,000 | 85.06% | 0.08% |
| March 10, 2026 | MCCOURT Thomas A | Chief Executive Officer | A | Class A Common Stock | 409836 | $0.00 | 1,898,838.0000 | 162,983,000 | 27.52% | 0.25% |
| March 10, 2026 | Gaskins Tammi L | Chief Commercial Officer | A | Class A Common Stock | 136612 | $0.00 | 350,350.0000 | 162,983,000 | 63.92% | 0.08% |
| March 10, 2026 | Shetzline Michael | SVP, CMO, Head-Res&Drug | A | Class A Common Stock | 136612 | $0.00 | 658,037.0000 | 162,983,000 | 26.20% | 0.08% |
| March 10, 2026 | Silver Ronald | Principal Accounting Officer | A | Class A Common Stock | 163934 | $0.00 | 416,570.0000 | 162,983,000 | 64.89% | 0.10% |
| Feb. 24, 2026 | Silver Ronald | Principal Accounting Officer | S | Class A Common Stock | 12621 | $3.66 | 252,636.0000 | 162,983,000 | 4.76% | 0.01% |
| Feb. 23, 2026 | Shetzline Michael | SVP, CMO, Head-Res&Drug | S | Class A Common Stock | 15570 | $3.81 | 538,437.0000 | 162,983,000 | 2.81% | 0.01% |
| Feb. 24, 2026 | Shetzline Michael | SVP, CMO, Head-Res&Drug | S | Common Stock | 17012 | $3.66 | 521,425.0000 | 162,983,000 | 3.37% | 0.01% |
| Feb. 23, 2026 | Gaskins Tammi L | Chief Commercial Officer | S | Class A Common Stock | 10287 | $3.81 | 224,977.0000 | 162,983,000 | 4.37% | 0.01% |
| Feb. 24, 2026 | Gaskins Tammi L | Chief Commercial Officer | S | Class A Common Stock | 11239 | $3.66 | 213,738.0000 | 162,983,000 | 5.00% | 0.01% |
| Feb. 23, 2026 | MCCOURT Thomas A | Chief Executive Officer | S | Class A Common Stock | 94757 | $3.81 | 1,592,528.0000 | 162,983,000 | 5.62% | 0.06% |
| Feb. 24, 2026 | MCCOURT Thomas A | Chief Executive Officer | S | Class A Common Stock | 103526 | $3.66 | 1,489,002.0000 | 162,983,000 | 6.50% | 0.06% |
| Feb. 23, 2026 | Martini Gregory S. | Chief Financial Officer | S | Class A Common Stock | 10487 | $3.81 | 172,058.0000 | 162,983,000 | 5.74% | 0.01% |
| Feb. 24, 2026 | Martini Gregory S. | Chief Financial Officer | S | Class A Common Stock | 11457 | $3.66 | 160,601.0000 | 162,983,000 | 6.66% | 0.01% |
| Feb. 23, 2026 | Silver Ronald | Principal Accounting Officer | S | Class A Common Stock | 11552 | $3.81 | 265,257.0000 | 162,983,000 | 4.17% | 0.01% |
| Feb. 23, 2026 | John Minardo | Chief Legal Officer | S | Class A Common Stock | 17439 | $3.81 | 382,939.0000 | 162,983,000 | 4.36% | 0.01% |
| Feb. 24, 2026 | John Minardo | Chief Legal Officer | S | Class A Common Stock | 19053 | $3.66 | 363,886.0000 | 162,983,000 | 4.98% | 0.01% |
| Jan. 5, 2026 | Silver Ronald | Principal Accounting Officer | S | Class A Common Stock | 35416 | $4.60 | 276,809.0000 | 162,983,000 | 11.34% | 0.02% |
| Dec. 15, 2025 | DENNER ALEXANDER J | Not found | A | Class A Common Stock | 4178 | $0.00 | 16,171,293.0000 | 177,764,000 | 0.03% | 0.00% |
| Nov. 17, 2025 | Gaskins Tammi L | Chief Commercial Officer | S | Class A Common Stock | 6016 | $3.32 | 235,264.0000 | 177,764,000 | 2.49% | 0.00% |
| Sept. 15, 2025 | DENNER ALEXANDER J | Not found | A | Class A Common Stock | 11718 | $0.00 | 16,167,115.0000 | 176,837,000 | 0.07% | 0.01% |
| Aug. 11, 2025 | Silver Ronald | Principal Accounting Officer | S | Class A Common Stock | 2846 | $0.84 | 276,809.0000 | 176,837,000 | 1.02% | 0.00% |
| Aug. 11, 2025 | John Minardo | Chief Legal Officer | S | Class A Common Stock | 7754 | $0.84 | 400,378.0000 | 176,837,000 | 1.90% | 0.00% |
| Aug. 11, 2025 | Martini Gregory S. | Chief Financial Officer | S | Class A Common Stock | 1265 | $0.84 | 182,545.0000 | 176,837,000 | 0.69% | 0.00% |
| Aug. 11, 2025 | Gaskins Tammi L | Chief Commercial Officer | S | Class A Common Stock | 1316 | $0.84 | 241,280.0000 | 176,837,000 | 0.54% | 0.00% |
| June 13, 2025 | DENNER ALEXANDER J | Not found | A | Class A Common Stock | 24193 | $0.00 | 16,625,962.0000 | 160,974,000 | 0.15% | 0.02% |
| June 10, 2025 | Duane Jon R | Not found | A | Class A Common Stock | 45000 | $0.00 | 190,339.0000 | 160,974,000 | 30.96% | 0.03% |
| June 10, 2025 | Kessler Marla L | Not found | A | Class A Common Stock | 45000 | $0.00 | 165,883.0000 | 160,974,000 | 37.23% | 0.03% |
| June 10, 2025 | Shepard Jay | Not found | A | Class A Common Stock | 45000 | $0.00 | 171,555.0000 | 160,974,000 | 35.56% | 0.03% |
| June 10, 2025 | Moukheibir Catherine | Not found | A | Class A Common Stock | 45000 | $0.00 | 117,944.0000 | 160,974,000 | 61.69% | 0.03% |
| June 10, 2025 | Currie Mark G | Not found | A | Class A Common Stock | 45000 | $0.00 | 613,419.0000 | 160,974,000 | 7.92% | 0.03% |
| June 10, 2025 | McHugh Julie | Not found | A | Class A Common Stock | 45000 | $0.00 | 208,839.0000 | 160,974,000 | 27.47% | 0.03% |
| June 10, 2025 | Dreyfus Andrew | Not found | A | Class A Common Stock | 45000 | $0.00 | 228,313.0000 | 160,974,000 | 24.55% | 0.03% |
| June 10, 2025 | DENNER ALEXANDER J | Not found | A | Class A Common Stock | 45000 | $0.00 | 16,601,769.0000 | 160,974,000 | 0.27% | 0.03% |
| May 16, 2025 | Gaskins Tammi L | Chief Commercial Officer | S | Class A Common Stock | 2563 | $0.58 | 242,596.0000 | 160,974,000 | 1.05% | 0.00% |
| May 16, 2025 | MCCOURT Thomas A | Chief Executive Officer | S | Class A Common Stock | 13353 | $0.58 | 1,147,281.0000 | 160,974,000 | 1.15% | 0.01% |
| May 20, 2025 | MCCOURT Thomas A | Chief Executive Officer | A | Class A Common Stock | 540000 | $0.00 | 1,687,281.0000 | 160,974,000 | 47.07% | 0.34% |
| April 2, 2025 | DENNER ALEXANDER J | Not found | A | Class A Common Stock | 10416 | $0.00 | 16,556,769.0000 | 160,974,000 | 0.06% | 0.01% |
| Feb. 10, 2025 | John Minardo | Chief Legal Officer | A | Class A Common Stock | 122222 | $0.00 | 447,070.0000 | 160,084,000 | 37.62% | 0.08% |
| Feb. 10, 2025 | Shetzline Michael | SVP, CMO, Head-Res&Drug | S | Class A Common Stock | 41269 | $1.76 | 554,007.0000 | 160,084,000 | 6.93% | 0.03% |
| Feb. 10, 2025 | MCCOURT Thomas A | Chief Executive Officer | S | Class A Common Stock | 139064 | $1.76 | 1,160,634.0000 | 160,084,000 | 10.70% | 0.09% |
| Feb. 10, 2025 | Shetzline Michael | SVP, CMO, Head-Res&Drug | A | Class A Common Stock | 133333 | $0.00 | 595,276.0000 | 160,084,000 | 28.86% | 0.08% |
| Feb. 10, 2025 | Martini Gregory S. | Chief Financial Officer | S | Class A Common Stock | 12052 | $1.76 | 183,810.0000 | 160,084,000 | 6.15% | 0.01% |
| Feb. 10, 2025 | John Minardo | Chief Legal Officer | S | Class A Common Stock | 38938 | $1.76 | 408,132.0000 | 160,084,000 | 8.71% | 0.02% |
| Feb. 10, 2025 | Silver Ronald | Principal Accounting Officer | S | Class A Common Stock | 12048 | $1.76 | 279,655.0000 | 160,084,000 | 4.13% | 0.01% |
| Jan. 27, 2025 | Martini Gregory S. | Chief Financial Officer | A | Class A Common Stock | 111111 | $0.00 | 195,862.0000 | 160,084,000 | 131.10% | 0.07% |
| Jan. 27, 2025 | Silver Ronald | Principal Accounting Officer | A | Class A Common Stock | 133333 | $0.00 | 291,703.0000 | 160,084,000 | 84.19% | 0.08% |
| Jan. 17, 2025 | Shetzline Michael | SVP, CMO, Head-Res&Drug | A | Class A Common Stock | 48224 | $0.00 | 461,943.0000 | 160,084,000 | 11.66% | 0.03% |
| Jan. 17, 2025 | MCCOURT Thomas A | Chief Executive Officer | A | Class A Common Stock | 147354 | $0.00 | 1,299,698.0000 | 160,084,000 | 12.79% | 0.09% |
| Jan. 17, 2025 | John Minardo | Chief Legal Officer | A | Class A Common Stock | 40187 | $0.00 | 324,848.0000 | 160,084,000 | 14.12% | 0.03% |
| Dec. 16, 2024 | DENNER ALEXANDER J | Not found | A | Class A Common Stock | 4249 | $0.00 | 16,546,353.0000 | 160,232,000 | 0.03% | 0.00% |
| Nov. 18, 2024 | Emany Sravan Kumar | SVP, COO and CFO | S | Class A Common Stock | 11001 | $4.08 | 309,572.0000 | 160,232,000 | 3.43% | 0.01% |
| Nov. 18, 2024 | Davis Andrew | SVP, Chief Business Officer | S | Class A Common Stock | 5360 | $4.08 | 284,685.0000 | 160,232,000 | 1.85% | 0.00% |
| Sept. 16, 2024 | DENNER ALEXANDER J | Not found | A | Class A Common Stock | 3282 | $0.00 | 16,542,104.0000 | 159,014,000 | 0.02% | 0.00% |
| Aug. 12, 2024 | John Minardo | Chief Legal Officer | S | Class A Common Stock | 9910 | $4.27 | 284,661.0000 | 159,014,000 | 3.36% | 0.01% |
| Aug. 12, 2024 | Silver Ronald | Principal Accounting Officer | S | Class A Common Stock | 3107 | $4.27 | 158,370.0000 | 159,014,000 | 1.92% | 0.00% |
| June 18, 2024 | Shepard Jay | Not found | A | Class A Common Stock | 24311 | $0.00 | 126,555.0000 | 157,700,000 | 23.78% | 0.02% |
| June 18, 2024 | Dreyfus Andrew | Not found | A | Class A Common Stock | 24311 | $0.00 | 188,230.0000 | 157,700,000 | 14.83% | 0.02% |
| June 18, 2024 | Duane Jon R | Not found | A | Class A Common Stock | 24311 | $0.00 | 145,339.0000 | 157,700,000 | 20.09% | 0.02% |
| June 18, 2024 | Moukheibir Catherine | Not found | A | Class A Common Stock | 24311 | $0.00 | 72,944.0000 | 157,700,000 | 49.99% | 0.02% |
| June 18, 2024 | McHugh Julie | Not found | A | Class A Common Stock | 24311 | $0.00 | 163,839.0000 | 157,700,000 | 17.42% | 0.02% |
| June 18, 2024 | Kessler Marla L | Not found | A | Class A Common Stock | 24311 | $0.00 | 120,883.0000 | 157,700,000 | 25.17% | 0.02% |
| June 18, 2024 | DENNER ALEXANDER J | Not found | A | Class A Common Stock | 24311 | $0.00 | 16,538,822.0000 | 157,700,000 | 0.15% | 0.02% |
| June 18, 2024 | Currie Mark G | Not found | A | Class A Common Stock | 24311 | $0.00 | 568,419.0000 | 157,700,000 | 4.47% | 0.02% |
| June 15, 2024 | DENNER ALEXANDER J | Not found | A | Class A Common Stock | 2572 | $0.00 | 16,514,511.0000 | 157,700,000 | 0.02% | 0.00% |
| June 10, 2024 | McHugh Julie | Not found | S | Class A Common Stock | 22766 | $6.29 | 139,528.0000 | 157,700,000 | 14.03% | 0.01% |
| June 6, 2024 | Moukheibir Catherine | Not found | S | Class A Common Stock | 44426 | $6.36 | 84,207.0000 | 157,700,000 | 34.54% | 0.03% |
| June 7, 2024 | Moukheibir Catherine | Not found | S | Class A Common Stock | 35574 | $6.61 | 48,633.0000 | 157,700,000 | 42.25% | 0.02% |
| May 20, 2024 | John Minardo | Chief Legal Officer | S | Class A Common Stock | 17404 | $6.45 | 294,571.0000 | 157,700,000 | 5.58% | 0.01% |
| May 20, 2024 | Shetzline Michael | CMO,SVP,Head-Res&Drug | S | Class A Common Stock | 16128 | $6.45 | 413,719.0000 | 157,700,000 | 3.75% | 0.01% |
| May 20, 2024 | Davis Andrew | SVP, Chief Business Officer | S | Class A Common Stock | 22725 | $6.45 | 288,031.0000 | 157,700,000 | 7.31% | 0.01% |
| May 20, 2024 | MCCOURT Thomas A | Chief Executive Officer | S | Class A Common Stock | 67618 | $6.45 | 1,150,330.0000 | 157,700,000 | 5.55% | 0.04% |
| May 16, 2024 | Emany Sravan Kumar | SVP, Chief Financial Officer | F | Class A Common Stock | 18280 | $6.64 | 320,573.0000 | 157,700,000 | 5.39% | 0.01% |
| March 15, 2024 | DENNER ALEXANDER J | Not found | A | Class A Common Stock | 1662 | $0.00 | 16,511,939.0000 | 155,435,000 | 0.01% | 0.00% |
| March 8, 2024 | John Minardo | Chief Legal Officer | M | Class A Common Stock | 32752 | $0.00 | 311,975.0000 | 155,435,000 | 11.73% | 0.02% |
| March 8, 2024 | MCCOURT Thomas A | Chief Executive Officer | M | Performance-based Restricted Stock Unit | 120298 | $0.00 | 0.0000 | 155,435,000 | 100.00% | 0.08% |
| March 8, 2024 | MCCOURT Thomas A | Chief Executive Officer | M | Class A Common Stock | 120298 | $0.00 | 1,217,948.0000 | 155,435,000 | 10.96% | 0.08% |
| March 8, 2024 | Davis Andrew | SVP, Chief Business Officer | M | Performance-based Restricted Stock Unit | 37120 | $0.00 | 0.0000 | 155,435,000 | 100.00% | 0.02% |
| March 8, 2024 | Davis Andrew | SVP, Chief Business Officer | M | Class A Common Stock | 37120 | $0.00 | 310,756.0000 | 155,435,000 | 13.57% | 0.02% |
| March 8, 2024 | Shetzline Michael | CMO,SVP,Head-Res&Drug | M | Performance-based Restricted Stock Unit | 34936 | $0.00 | 0.0000 | 155,435,000 | 100.00% | 0.02% |
| March 8, 2024 | Shetzline Michael | CMO,SVP,Head-Res&Drug | M | Class A Common Stock | 34936 | $0.00 | 429,847.0000 | 155,435,000 | 8.85% | 0.02% |
| March 8, 2024 | Emany Sravan Kumar | SVP, Chief Financial Officer | M | Performance-based Restricted Stock Unit | 37120 | $0.00 | 0.0000 | 155,435,000 | 100.00% | 0.02% |
| March 8, 2024 | Emany Sravan Kumar | SVP, Chief Financial Officer | M | Class A Common Stock | 37120 | $0.00 | 338,853.0000 | 155,435,000 | 12.30% | 0.02% |
| March 8, 2024 | John Minardo | Chief Legal Officer | M | Performance-based Restricted Stock Unit | 32752 | $0.00 | 0.0000 | 155,435,000 | 100.00% | 0.02% |
| March 6, 2024 | Duane Jon R | Not found | P | Class A Common Stock | 6920 | $8.70 | 121,028.0000 | 155,435,000 | 6.06% | 0.00% |
| March 5, 2024 | MCCOURT Thomas A | Chief Executive Officer | A | Class A Common Stock | 264876 | $0.00 | 1,097,650.0000 | 155,435,000 | 31.81% | 0.17% |
| March 5, 2024 | MCCOURT Thomas A | Chief Executive Officer | A | Performance-based Restricted Stock Unit | 132438 | $0.00 | 132,438.0000 | 155,435,000 | 9999.99% | 0.09% |
| March 4, 2024 | Emany Sravan Kumar | SVP, Chief Financial Officer | P | Class A Common Stock | 10684 | $9.38 | 301,733.0000 | 155,435,000 | 3.67% | 0.01% |
| Feb. 12, 2024 | Shetzline Michael | CMO,SVP,Head-Res&Drug | A | Performance-based Restricted Stock Unit | 27214 | $0.00 | 27,214.0000 | 155,435,000 | 9999.99% | 0.02% |
| Feb. 12, 2024 | MCCOURT Thomas A | Chief Executive Officer | S | Class A Common Stock | 177164 | $15.24 | 832,774.0000 | 155,435,000 | 17.54% | 0.11% |
| Feb. 12, 2024 | Emany Sravan Kumar | SVP, Chief Financial Officer | A | Performance-based Restricted Stock Unit | 32656 | $0.00 | 32,656.0000 | 155,435,000 | 9999.99% | 0.02% |
| Feb. 12, 2024 | Emany Sravan Kumar | SVP, Chief Financial Officer | A | Class A Common Stock | 65312 | $0.00 | 291,049.0000 | 155,435,000 | 28.93% | 0.04% |
| Feb. 12, 2024 | Davis Andrew | SVP, Chief Business Officer | A | Performance-based Restricted Stock Unit | 32656 | $0.00 | 32,656.0000 | 155,435,000 | 9999.99% | 0.02% |
| Feb. 12, 2024 | Davis Andrew | SVP, Chief Business Officer | A | Class A Common Stock | 65312 | $0.00 | 273,636.0000 | 155,435,000 | 31.35% | 0.04% |
| Feb. 12, 2024 | Davis Andrew | SVP, Chief Business Officer | S | Class A Common Stock | 9846 | $15.24 | 208,324.0000 | 155,435,000 | 4.51% | 0.01% |
| Feb. 12, 2024 | Silver Ronald | Principal Accounting Officer | A | Class A Common Stock | 27213 | $0.00 | 161,477.0000 | 155,435,000 | 20.27% | 0.02% |
| Feb. 12, 2024 | Silver Ronald | Principal Accounting Officer | S | Class A Common Stock | 7908 | $15.24 | 134,264.0000 | 155,435,000 | 5.56% | 0.01% |
| Feb. 12, 2024 | Shetzline Michael | CMO,SVP,Head-Res&Drug | S | Class A Common Stock | 38618 | $15.24 | 340,484.0000 | 155,435,000 | 10.19% | 0.02% |
| Feb. 12, 2024 | Shetzline Michael | CMO,SVP,Head-Res&Drug | A | Class A Common Stock | 54427 | $0.00 | 394,911.0000 | 155,435,000 | 15.99% | 0.04% |
| Feb. 12, 2024 | John Minardo | Chief Legal Officer | S | Class A Common Stock | 47380 | $15.24 | 224,796.0000 | 155,435,000 | 17.41% | 0.03% |
| Feb. 12, 2024 | John Minardo | Chief Legal Officer | A | Class A Common Stock | 54427 | $0.00 | 279,223.0000 | 155,435,000 | 24.21% | 0.04% |
| Feb. 12, 2024 | John Minardo | Chief Legal Officer | A | Performance-based Restricted Stock Unit | 27214 | $0.00 | 27,214.0000 | 155,435,000 | 9999.99% | 0.02% |
| Feb. 8, 2024 | Emany Sravan Kumar | SVP, Chief Financial Officer | F | Class A Common Stock | 41332 | $14.90 | 225,737.0000 | 155,435,000 | 15.48% | 0.03% |
| Jan. 17, 2024 | Shetzline Michael | CMO,SVP,Head-Res&Drug | A | Class A Common Stock | 57971 | $0.00 | 379,102.0000 | 155,435,000 | 18.05% | 0.04% |
| Jan. 17, 2024 | Emany Sravan Kumar | SVP, Chief Financial Officer | A | Class A Common Stock | 85000 | $0.00 | 267,069.0000 | 155,435,000 | 46.69% | 0.05% |
| Jan. 17, 2024 | MCCOURT Thomas A | Chief Executive Officer | A | Class A Common Stock | 249617 | $0.00 | 1,009,938.0000 | 155,435,000 | 32.83% | 0.16% |
| Jan. 17, 2024 | John Minardo | Chief Legal Officer | A | Class A Common Stock | 79981 | $0.00 | 272,176.0000 | 155,435,000 | 41.61% | 0.05% |
| Dec. 15, 2023 | Moukheibir Catherine | Director | A | Class A Common Stock | 1572 | $0.00 | 128,633.0000 | 186,891,000 | 1.24% | 0.00% |
| Dec. 15, 2023 | DENNER ALEXANDER J | Director | A | Class A Common Stock | 1347 | $0.00 | 16,510,277.0000 | 186,891,000 | 0.01% | 0.00% |
| Dec. 14, 2023 | Kessler Marla L | Director | S | Class A Common Stock | 9926 | $11.19 | 96,572.0000 | 186,891,000 | 9.32% | 0.01% |
| Nov. 20, 2023 | Davis Andrew | SVP, Chief Business Officer | S | Class A Common Stock | 3287 | $9.69 | 217,374.0000 | 186,891,000 | 1.49% | 0.00% |
| Nov. 16, 2023 | Emany Sravan Kumar | SVP, Chief Financial Officer | F | Class A Common Stock | 6661 | $9.44 | 182,069.0000 | 186,891,000 | 3.53% | 0.00% |
| Sept. 15, 2023 | Moukheibir Catherine | Director | A | Class A Common Stock | 2098 | $0.00 | 127,061.0000 | 155,367,000 | 1.68% | 0.00% |
| Sept. 15, 2023 | DENNER ALEXANDER J | Director | A | Class A Common Stock | 1798 | $0.00 | 16,508,930.0000 | 155,367,000 | 0.01% | 0.00% |
| Sept. 15, 2023 | Emany Sravan Kumar | SVP, Chief Financial Officer | P | Class A Common Stock | 36072 | $8.32 | 188,730.0000 | 155,367,000 | 23.63% | 0.02% |
| Aug. 29, 2023 | Silver Ronald | Principal Accounting Officer | A | Class A Common Stock | 8000 | $0.00 | 142,172.0000 | 155,367,000 | 5.96% | 0.01% |
| Aug. 14, 2023 | John Minardo | Chief Legal Officer | S | Class A Common Stock | 7045 | $10.04 | 192,195.0000 | 155,367,000 | 3.54% | 0.00% |
| Aug. 14, 2023 | Silver Ronald | Principal Accounting Officer | S | Class A Common Stock | 1976 | $10.04 | 134,172.0000 | 155,367,000 | 1.45% | 0.00% |
| June 20, 2023 | Currie Mark G | Director | A | Class A Common Stock | 22350 | $0.00 | 544,108.0000 | 186,680,000 | 4.28% | 0.01% |
| June 20, 2023 | Shepard Jay | Director | A | Class A Common Stock | 22350 | $0.00 | 102,244.0000 | 186,680,000 | 27.97% | 0.01% |
| June 20, 2023 | Moukheibir Catherine | Director | A | Class A Common Stock | 22350 | $0.00 | 124,963.0000 | 186,680,000 | 21.78% | 0.01% |
| June 20, 2023 | McHugh Julie | Director | A | Class A Common Stock | 22350 | $0.00 | 162,294.0000 | 186,680,000 | 15.97% | 0.01% |
| June 20, 2023 | Kessler Marla L | Director | A | Class A Common Stock | 22350 | $0.00 | 106,498.0000 | 186,680,000 | 26.56% | 0.01% |
| June 20, 2023 | Duane Jon R | Director | A | Class A Common Stock | 22350 | $0.00 | 114,108.0000 | 186,680,000 | 24.36% | 0.01% |
| June 20, 2023 | Dreyfus Andrew | Director | A | Class A Common Stock | 22350 | $0.00 | 168,980.0000 | 186,680,000 | 15.24% | 0.01% |
| June 20, 2023 | DENNER ALEXANDER J | Director | A | Class A Common Stock | 22350 | $0.00 | 16,507,132.0000 | 186,680,000 | 0.14% | 0.01% |
| June 15, 2023 | Moukheibir Catherine | Director | A | Class A Common Stock | 1586 | $0.00 | 102,613.0000 | 186,680,000 | 1.57% | 0.00% |
| June 15, 2023 | DENNER ALEXANDER J | Director | A | Class A Common Stock | 1359 | $0.00 | 16,484,782.0000 | 186,680,000 | 0.01% | 0.00% |
| May 30, 2023 | MCCOURT Thomas A | Chief Executive Officer | S | Class A Common Stock | 26632 | $10.70 | 758,284.0000 | 186,680,000 | 3.39% | 0.01% |
| May 22, 2023 | Shetzline Michael | CMO,SVP,Head-Res&Drug | S | Class A Common Stock | 10324 | $10.12 | 321,131.0000 | 186,680,000 | 3.11% | 0.01% |
| May 22, 2023 | MCCOURT Thomas A | Chief Executive Officer | S | Class A Common Stock | 36000 | $10.12 | 784,916.0000 | 186,680,000 | 4.39% | 0.02% |
| May 22, 2023 | Davis Andrew | SVP, Chief Business Officer | S | Class A Common Stock | 6305 | $10.12 | 219,327.0000 | 186,680,000 | 2.79% | 0.00% |
| May 8, 2023 | MCCOURT Thomas A | Chief Executive Officer | S | Class A Common Stock | 21148 | $10.62 | 820,916.0000 | 186,680,000 | 2.51% | 0.01% |
| March 27, 2023 | MCCOURT Thomas A | Chief Executive Officer | S | Class A Common Stock | 46129 | $10.67 | 842,064.0000 | 186,312,000 | 5.19% | 0.02% |
| March 15, 2023 | DENNER ALEXANDER J | Director | A | Class A Common Stock | 1438 | $0.00 | 16,483,423.0000 | 186,312,000 | 0.01% | 0.00% |
| March 15, 2023 | Moukheibir Catherine | Director | A | Class A Common Stock | 1677 | $0.00 | 101,027.0000 | 186,312,000 | 1.69% | 0.00% |
| March 8, 2023 | Shetzline Michael | CMO,SVP,Head-Res&Drug | A | Performance-based Restricted Stock Units | 34935 | $0.00 | 34,935.0000 | 186,312,000 | 9999.99% | 0.02% |
| March 8, 2023 | Rickard Jason | SVP, Chief Operating Officer | A | Class A Common Stock | 43668 | $0.00 | 376,316.0000 | 186,312,000 | 13.13% | 0.02% |
| March 8, 2023 | Rickard Jason | SVP, Chief Operating Officer | A | Performance-based Restricted Stock Units | 21834 | $0.00 | 21,834.0000 | 186,312,000 | 9999.99% | 0.01% |
| March 8, 2023 | John Minardo | Chief Legal Officer | A | Class A Common Stock | 65502 | $0.00 | 199,240.0000 | 186,312,000 | 48.98% | 0.04% |
| March 8, 2023 | John Minardo | Chief Legal Officer | A | Performance-based Restricted Stock Units | 32751 | $0.00 | 32,751.0000 | 186,312,000 | 9999.99% | 0.02% |
| March 8, 2023 | MCCOURT Thomas A | Chief Executive Officer | A | Class A Common Stock | 240595 | $0.00 | 888,193.0000 | 186,312,000 | 37.15% | 0.13% |
| March 8, 2023 | MCCOURT Thomas A | Chief Executive Officer | A | Performance-based Restricted Stock Units | 120297 | $0.00 | 120,297.0000 | 186,312,000 | 9999.99% | 0.06% |
| March 8, 2023 | Emany Sravan Kumar | SVP, Chief Financial Officer | A | Class A Common Stock | 74236 | $0.00 | 152,658.0000 | 186,312,000 | 94.66% | 0.04% |
| March 8, 2023 | Emany Sravan Kumar | SVP, Chief Financial Officer | A | Performance-based Restricted Stock Units | 37118 | $0.00 | 37,118.0000 | 186,312,000 | 9999.99% | 0.02% |
| March 8, 2023 | Davis Andrew | SVP, Chief Business Officer | A | Class A Common Stock | 74236 | $0.00 | 225,632.0000 | 186,312,000 | 49.03% | 0.04% |
| March 8, 2023 | Davis Andrew | SVP, Chief Business Officer | A | Performance-based Restricted Stock Units | 37118 | $0.00 | 37,118.0000 | 186,312,000 | 9999.99% | 0.02% |
| March 8, 2023 | Shetzline Michael | CMO,SVP,Head-Res&Drug | A | Class A Common Stock | 69869 | $0.00 | 331,455.0000 | 186,312,000 | 26.71% | 0.04% |
| March 8, 2023 | Silver Ronald | Principal Accounting Officer | A | Class A Common Stock | 35620 | $0.00 | 134,111.0000 | 186,312,000 | 36.17% | 0.02% |
| March 3, 2023 | MCCOURT Thomas A | Chief Executive Officer | S | Class A Common Stock | 33756 | $11.22 | 647,598.0000 | 186,312,000 | 4.95% | 0.02% |
| Feb. 27, 2023 | Rickard Jason | SVP, Chief Operating Officer | S | Class A Common Stock | 3308 | $11.41 | 350,077.0000 | 186,312,000 | 0.94% | 0.00% |
| Feb. 28, 2023 | Davis Andrew | SVP, Chief Business Officer | S | Class A Common Stock | 1822 | $11.31 | 151,396.0000 | 186,312,000 | 1.19% | 0.00% |
| Feb. 28, 2023 | Silver Ronald | Principal Accounting Officer | S | Class A Common Stock | 3049 | $11.31 | 98,491.0000 | 186,312,000 | 3.00% | 0.00% |
| Feb. 27, 2023 | Rickard Jason | SVP, Chief Operating Officer | S | Class A Common Stock | 13438 | $11.41 | 353,385.0000 | 186,312,000 | 3.66% | 0.01% |
| Feb. 27, 2023 | Silver Ronald | Principal Accounting Officer | S | Class A Common Stock | 2929 | $11.41 | 101,540.0000 | 186,312,000 | 2.80% | 0.00% |
| Feb. 27, 2023 | Davis Andrew | SVP, Chief Business Officer | S | Class A Common Stock | 1751 | $11.41 | 153,218.0000 | 186,312,000 | 1.13% | 0.00% |
| Feb. 28, 2023 | John Minardo | Chief Legal Officer | S | Class A Common Stock | 3415 | $11.31 | 133,738.0000 | 186,312,000 | 2.49% | 0.00% |
| Feb. 27, 2023 | John Minardo | Chief Legal Officer | S | Class A Common Stock | 3282 | $11.41 | 137,153.0000 | 186,312,000 | 2.34% | 0.00% |
| Feb. 28, 2023 | Shetzline Michael | CMO,SVP,Head-Res&Drug | S | Class A Common Stock | 2416 | $11.31 | 261,586.0000 | 186,312,000 | 0.92% | 0.00% |
| Feb. 28, 2023 | Shetzline Michael | CMO,SVP,Head-Res&Drug | S | Class A Common Stock | 7438 | $11.31 | 264,002.0000 | 186,312,000 | 2.74% | 0.00% |
| Feb. 27, 2023 | Shetzline Michael | CMO,SVP,Head-Res&Drug | S | Class A Common Stock | 2322 | $11.41 | 271,440.0000 | 186,312,000 | 0.85% | 0.00% |
| Feb. 27, 2023 | Shetzline Michael | CMO,SVP,Head-Res&Drug | S | Class A Common Stock | 7146 | $11.41 | 273,762.0000 | 186,312,000 | 2.54% | 0.00% |
| Feb. 28, 2023 | MCCOURT Thomas A | Chief Executive Officer | S | Class A Common Stock | 4588 | $11.31 | 681,354.0000 | 186,312,000 | 0.67% | 0.00% |
| Feb. 28, 2023 | MCCOURT Thomas A | Chief Executive Officer | S | Class A Common Stock | 26639 | $11.31 | 685,942.0000 | 186,312,000 | 3.74% | 0.01% |
| Feb. 27, 2023 | MCCOURT Thomas A | Chief Executive Officer | S | Class A Common Stock | 4409 | $11.41 | 712,581.0000 | 186,312,000 | 0.61% | 0.00% |
| Feb. 27, 2023 | MCCOURT Thomas A | Chief Executive Officer | S | Class A Common Stock | 25595 | $11.41 | 716,990.0000 | 186,312,000 | 3.45% | 0.01% |
| Feb. 28, 2023 | Rickard Jason | SVP, Chief Operating Officer | S | Class A Common Stock | 13987 | $11.31 | 336,090.0000 | 186,312,000 | 4.00% | 0.01% |
| Feb. 28, 2023 | Rickard Jason | SVP, Chief Operating Officer | S | Class A Common Stock | 3442 | $11.31 | 332,648.0000 | 186,312,000 | 1.02% | 0.00% |
| Jan. 17, 2023 | Shetzline Michael | CMO,SVP,Head-Res&Drug | A | Class A Common Stock | 14663 | $0.00 | 280,908.0000 | 186,312,000 | 5.51% | 0.01% |
| Jan. 17, 2023 | MCCOURT Thomas A | Chief Executive Officer | A | Class A Common Stock | 30145 | $0.00 | 742,585.0000 | 186,312,000 | 4.23% | 0.02% |
| Jan. 17, 2023 | Rickard Jason | SVP, Chief Operating Officer | A | Class A Common Stock | 18087 | $0.00 | 366,823.0000 | 186,312,000 | 5.19% | 0.01% |
| Jan. 5, 2023 | MCCOURT Thomas A | Chief Executive Officer | S | Class A Common Stock | 110962 | $12.07 | 712,440.0000 | 186,312,000 | 13.48% | 0.06% |
| Jan. 5, 2023 | MCCOURT Thomas A | Chief Executive Officer | M | Class A Common Stock | 110962 | $11.65 | 823,402.0000 | 186,312,000 | 15.57% | 0.06% |
| Jan. 5, 2023 | MCCOURT Thomas A | Chief Executive Officer | M | Employee Stock Options (Right to Buy) | 110962 | $0.00 | 0.0000 | 186,312,000 | 100.00% | 0.06% |